Comparison of the effects of etomidate and remazolam tosylate on hemodynamics in elderly patients

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042870

Enrollment

Unknown

Registered

2021-01-30

Start date

2021-02-26

Completion date

Unknown

Last updated

2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

general anesthesia

Interventions

Group R :remazolam tosylate

Group E :Etomidate

Eligibility

Sex/Gender

All

Age

65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 65-80 years; 2. Conscious; 3. No history of hypertension or well-controlled hypertension; 4. ASA score is II or III; 5. Surgery under general anesthesia.

Exclusion criteria

Exclusion criteria: 1.Multiple drug allergies; 2.Unexpectedly difficult airway; 3.Other unforeseen circumstances in the induction period.

Design outcomes

Primary

Measure	Time frame
blood pressure;heart rate;	—

Secondary

Measure	Time frame
The incidence of muscle fibrillation;Incidence of postoperative nausea and vomiting;	—

Countries

China

Contacts

Public ContactZhiming Zhang

Chenzhou First People's Hospital

Otc0735@163.com+86 13875555649

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026